Seven Fleet Capital Management LP Buys 51,727 Shares of Liquidia Corporation $LQDA

Posted by on Aug 27th, 2026

Seven Fleet Capital Management LP lifted its stake in shares of Liquidia Corporation (NASDAQ:LQDA – Free Report) by 25.2% during the second quarter, Holdings Channel reports. The firm owned 256,603 shares of the company’s stock after purchasing an additional 51,727 shares during the quarter. Liquidia makes up approximately 3.4% of Seven Fleet Capital Management LP’s portfolio, making the stock its 5th largest holding. Seven Fleet Capital Management LP’s holdings in Liquidia were worth $20,459,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the stock. AXQ Capital LP acquired a new position in shares of Liquidia in the 2nd quarter valued at $546,000. Nykredit A S acquired a new stake in Liquidia during the 2nd quarter worth about $177,000. Globeflex Capital L P purchased a new stake in Liquidia during the second quarter valued at about $175,000. Bank of New York Mellon Corp purchased a new stake in Liquidia during the second quarter valued at about $29,694,000. Finally, Handelsbanken Fonder AB acquired a new position in shares of Liquidia in the second quarter worth about $1,993,000. 64.54% of the stock is owned by hedge funds and other institutional investors.

Liquidia Trading Up 1.2%

Shares of NASDAQ:LQDA opened at $71.36 on Thursday. The company has a quick ratio of 2.12, a current ratio of 2.31 and a debt-to-equity ratio of 0.63. Liquidia Corporation has a 12-month low of $21.15 and a 12-month high of $93.61. The firm has a fifty day moving average of $79.36 and a two-hundred day moving average of $56.86. The firm has a market capitalization of $6.39 billion, a P/E ratio of 52.09 and a beta of 0.58.

Liquidia (NASDAQ:LQDA – Get Free Report) last issued its earnings results on Wednesday, August 12th. The company reported $0.74 EPS for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.02). Liquidia had a net margin of 30.74% and a return on equity of 149.65%. The firm had revenue of $171.68 million during the quarter, compared to analysts’ expectations of $168.48 million. During the same quarter last year, the firm earned ($0.49) EPS. The business’s revenue for the quarter was up 1842.1% compared to the same quarter last year. On average, equities analysts expect that Liquidia Corporation will post 2.57 EPS for the current fiscal year.

Insider Buying and Selling at Liquidia

In related news, Director Katherine Rielly-Gauvin sold 18,393 shares of the firm’s stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $72.23, for a total transaction of $1,328,526.39. Following the transaction, the director owned 44,637 shares of the company’s stock, valued at approximately $3,224,130.51. This trade represents a 29.18% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stephen M. Bloch sold 100,000 shares of Liquidia stock in a transaction that occurred on Thursday, July 23rd. The shares were sold at an average price of $89.48, for a total transaction of $8,948,000.00. Following the completion of the sale, the director owned 501,477 shares of the company’s stock, valued at $44,872,161.96. This trade represents a 16.63% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 1,854,286 shares of company stock worth $131,450,837 over the last quarter. Insiders own 25.60% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently weighed in on LQDA shares. Bank of America lifted their target price on shares of Liquidia from $79.00 to $92.00 and gave the stock a “neutral” rating in a research report on Thursday, August 13th. Wells Fargo & Company raised their price objective on shares of Liquidia from $62.00 to $108.00 and gave the stock an “overweight” rating in a research note on Thursday, August 13th. Oppenheimer set a $75.00 price objective on shares of Liquidia in a research note on Friday, June 5th. Stephens set a $130.00 price objective on shares of Liquidia in a research report on Friday, July 24th. Finally, Wall Street Zen downgraded shares of Liquidia from a “strong-buy” rating to a “buy” rating in a research note on Saturday, June 27th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, Liquidia currently has a consensus rating of “Hold” and a consensus target price of $98.08.

View Our Latest Stock Report on LQDA

Liquidia Company Profile

(Free Report)

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).

Read More

Want to see what other hedge funds are holding LQDA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Liquidia Corporation (NASDAQ:LQDA – Free Report).

Institutional Ownership by Quarter for Liquidia (NASDAQ:LQDA)

Receive News & Ratings for Liquidia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia and related companies with MarketBeat.com's FREE daily email newsletter.